LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

Swiss National Bank's Holding History (CIK: 0001582202)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 247,400 Value ($000) $341 Avg Close — Range —
Q2 2024
Shares 247,400 Value ($000) $359 Avg Close — Range —
Q1 2024
Shares 247,400 Value ($000) $552 Avg Close — Range —
Q4 2023
Shares 247,400 Value ($000) $480 Avg Close — Range —
Q3 2023
Shares 271,700 Value ($000) $399 Avg Close — Range —
Q2 2023
Shares 271,700 Value ($000) $864 Avg Close — Range —